An anti-inflammatory drug given to patients in the early stages of a stroke has been shown by researchers to reduce harmful inflammation. The drug, Kineret©, licensed for treating rheumatoid arthritis, was given as a small injection just under the skin without giving the patients any identifiable adverse reactions.